MYO vs NOC · rev $21.8M vs P/E 17, rev $20.76B
Myomo Inc (MYO) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Myomo Inc (MYO) is a medical devices company listed on AMEX.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported MYO revenue for 2026-06-30 was $21.8M. Net income was -$7.0M. MYO currently screens at market cap $57.6M.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
MYO currently screens at market cap $57.6M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the MYO and NOC stock pages for the full models.
Not investment advice.